Table 2.
Summary of dose intensification
| Dose intensification | Ulcerative colitis | Crohn’s disease | P value |
| (n = 38) | (n = 59) | ||
| Time on infliximab1 [median (interquartile range), mo] | 9 (5.2-12.5) | 13.1 (8.1-23.3) | 0.006 |
| Rate of intensification per patient-month | 3.9% | 1.4% | 0.005 |
| Time to infliximab intensification [median (interquartile range), mo] | 6.6 (4.2-9.5) | 10.7 (8.9-15.7) | 0.005 |
1
Time on infliximab: Interval of time between the first infliximab induction dose and the first infliximab intensified dose, or for patients who did not require dose intensification time between the initiation of infliximab and either the last follow-up visit or the time of infliximab discontinuation.